Registry for Hirschsprung Disease in Belgium
Registry for Hirschsprung Disease of the BELAPS (Belgian Association of Pediatric Surgery)
This study is collecting information about children in Belgium who have had surgery for Hirschsprung disease to see how their bowel habits change over time and to find ways to improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 432 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven) |
| Trial ID | NCT04622410 on ClinicalTrials.gov |
What this trial studies
This registry aims to collect pre-, intra-, and postoperative data for pediatric patients with Hirschsprung disease in Belgium. The primary goal is to assess defecation habits in children 3.5 to 5.5 years after surgical intervention. Additionally, the study will evaluate long-term outcomes and identify risk factors associated with constipation and incontinence. By systematically gathering this data, the registry seeks to enhance surgical care and improve patient quality of life.
Who should consider this trial
Good fit: Ideal candidates for this registry are pediatric patients diagnosed with Hirschsprung disease who have undergone surgery.
Not a fit: Patients who have not been diagnosed with Hirschsprung disease or those who have not undergone surgical treatment may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved surgical techniques and better long-term outcomes for children with Hirschsprung disease.
How similar studies have performed: While this registry approach is common in clinical settings, the specific focus on Hirschsprung disease outcomes in Belgium may provide novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Hirschsprung Disease, surgery Exclusion Criteria: \-
Where this trial is running
Leuven
- UZ Leuven — Leuven, Belgium (Recruiting)
Study contacts
- Study coordinator: Colette Barle
- Email: colette.barle@uzleuven.be
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.